- Normal 2.5–4.5 mg/dL. Mild 2.0–2.4 · moderate 1.0–1.9 · severe <1.0.
- Severe (<1.0) or symptoms (weakness, failure to wean, rhabdo, hemolysis) → IV phosphate.
- Mild–moderate, gut works → oral phosphate. It is safer and works.
- Pick the salt by the potassium: K <4 → potassium phosphate. K ≥4 or kidney failure → sodium phosphate.
- Kidney failure (CrCl <30): half the dose, then recheck.
- Refeeding risk? Thiamine first, feed slowly, check phos/K/Mg every 12 h for 3 days.
- Always check Mg, K and Ca at the same time — they travel together.
Pathophysiology in 60 seconds
⌄
- 85% of phosphate is in bone, most of the rest is inside cells. Only <1% is in the blood → the serum level is a small window on a big store.
- Phosphate is the "P" in ATP and in 2,3-DPG (which helps red cells release O₂).
- Kidney controls the level: PTH and FGF23 make the kidney spill phosphate. Vitamin D (calcitriol) helps the gut absorb it.
- Three ways to get low: phosphate shifts into cells, the kidney spills it, or not enough comes in.
Phosphate = the P in ATP. When the battery runs flat, the organs that burn the most energy stop first.
Phosphate is the battery of the cell. Low phos = dead batteries: the biggest power users fail first — the diaphragm, skeletal muscle, red cells, the brain and the heart.
Symptoms (usually only when <1.5, especially <1.0)
- Muscle: weakness, respiratory failure / failure to wean, rhabdomyolysis, ileus, dysphagia.
- Heart: low contractility, arrhythmias.
- Blood: hemolysis, poor O₂ release (low 2,3-DPG), WBC and platelet dysfunction.
- Brain: confusion, paresthesias, seizures, coma.
- Chronic: bone pain, osteomalacia, fractures.
Causes
⌄
Ferric carboxymaltose (Injectafer) raises intact FGF23 → the kidney spills phosphate. Hypophosphatemia in up to ~50–75% of patients (vs ~8% with ferric derisomaltose in PHOSPHARE). It can last weeks and cause osteomalacia with repeat doses. Ask about recent IV iron in any low phos without a clear cause.
- Who: little or no food for >5–10 days, BMI <16–18.5, weight loss >10–15%, alcohol use disorder, anorexia, cancer, post-bariatric, chronic diuretics or antacids.
- What: food → insulin → phosphate, K and Mg rush into cells → levels crash in 2–5 days → heart failure, arrhythmia, respiratory failure, death.
- ASPEN 2020: a drop of phos, K or Mg by 10–20% = mild, 20–30% = moderate, >30% (or organ dysfunction) = severe — within 5 days of feeding.
Diagnosis
⌄
- First ask: is there a shift? Just started insulin, feeding, glucose, or hyperventilating? Then the kidney is probably fine.
- Labs: phos, Mg, K, Ca, albumin, creatinine, glucose, CK (rhabdo), LDH/haptoglobin (hemolysis), 25-OH vitamin D, PTH.
- Urine (spot, before you replace): phos and creatinine → FEPO₄.
FEPO₄ = (urine P × serum Cr) ÷ (serum P × urine Cr) × 100
replace if low/symptomatic; recheck — kidney is fine
kidney is saving it → gut / intake: starvation, alcohol, diarrhea, binders, antacids, low vitamin D
kidney is spilling it → check Ca, PTH, 25-OH D, FGF23, urine glucose / amino acids
primary hyperPTH
vitamin D deficiency
FGF23 (IV iron, XLH, tumor) · Fanconi · drugs
1 mmol phosphorus = 31 mg. Serum mg/dL × 0.323 = mmol/L. Oral tablets are labeled in mg, IV bags in mmol — do not mix them up.
Management — easy replenishment guide
⌄
Step 1 — dose by level (use actual weight; adjusted weight if obese). Many hospitals use the fixed doses on the right.
| Serum phos (mg/dL) | Weight-based | Fixed dose (≈70 kg) |
|---|---|---|
| 2.0–2.4 (mild) | 0.16 mmol/kg | 15 mmol |
| 1.0–1.9 (moderate) | 0.32 mmol/kg | 30 mmol |
| <1.0 (severe) | 0.64 mmol/kg | 45 mmol (max ~50 mmol/dose) |
Step 2 — pick the salt:
| Product | Per 1 mL | When |
|---|---|---|
| Potassium phosphate | 3 mmol P + 4.4 mEq K | K <4.0, kidneys OK |
| Sodium phosphate | 3 mmol P + 4 mEq Na | K ≥4.0, CKD/AKI, on K-sparing drugs |
Step 3 — rate: usually ≤7.5 mmol/h (faster only in ICU per protocol).
| Order | Infuse over |
|---|---|
| NaPhos 15 mmol | 2 h |
| NaPhos 30 mmol | 4 h |
| KPhos 15 mmol (22 mEq K) | 3 h (K ≤10 mEq/h peripheral) |
| KPhos 30 mmol (44 mEq K) | 6 h |
Step 4 — CrCl <30 / AKI / dialysis: half dose. Recheck phos, K, Ca after.
Mild–moderate (1.0–2.4) and gut works: 250–500 mg (8–16 mmol) PO TID–QID → about 1–2 g/day.
| Product | Phosphorus | Na | K |
|---|---|---|---|
| K-Phos Neutral / Phospha 250 Neutral (tablet) | 250 mg (8 mmol) | 13 mEq | 1.1 mEq |
| Neutra-Phos / Phos-NaK (powder packet) | 250 mg (8 mmol) | 7.1 mEq | 7.1 mEq |
| Neutra-Phos-K (packet) | 250 mg (8 mmol) | 0 | 14.25 mEq |
| Skim milk, 1 cup (8 oz) | ~250 mg | — | — |
- Main side effect: diarrhea (dose-limiting). Split the dose, give with food.
- Give 2 h apart from calcium, Mg/Al antacids, sucralfate, sevelamer and other binders — they bind it.
- Neutra-Phos packet = good when K is also low (refeeding, DKA recovery, alcohol use).
- Phos 2.1, K 4.3, eating: K-Phos Neutral 1 tab (250 mg) PO TID × 3 doses → BMP/phos in AM.
- Phos 1.6, K 3.4, 70 kg, NPO: Potassium phosphate 30 mmol IV over 6 h → phos, K in AM.
- Phos 0.8, K 4.6, 80 kg, ventilated: Sodium phosphate 45 mmol IV over 6 h → phos 2–4 h after. Repeat if still <1.0.
- Phos 1.4, CrCl 22: Sodium phosphate 15 mmol IV over 2 h (half of 30) → recheck before more.
- Many hospitals have a nurse-driven electrolyte protocol — use it when the patient qualifies.
- Before feeding: thiamine 100–200 mg daily (IV/PO) for 5–7 days; start before the first meal or dextrose.
- Feed slowly: start 10–20 kcal/kg/day (5–10 if very high risk) → increase over 4–7 days.
- Labs: phos, K, Mg every 12 h for the first 3 days, then daily.
- Replace low levels before and during feeding. Do not stop feeding for mild drops — slow it down.
- Watch fluid (edema, HF) and telemetry in high-risk patients.
- DKA: phos falls with insulin — do not replace routinely. Replace if <1.0 mg/dL, or with cardiac dysfunction, hemolysis or respiratory depression (part of K replacement as KPhos).
- CRRT: effluent removes phosphate → use phosphate-containing replacement fluid or scheduled replacement.
- Hungry bone (after parathyroidectomy): Ca, phos and Mg all fall → calcium + calcitriol; replace phos carefully.
- Chronic renal wasting (X-linked hypophosphatemia, tumor-induced osteomalacia): oral phos + calcitriol; burosumab (anti-FGF23) for XLH. Endocrine.
Doses are typical adult doses. Check kidney function, Ca, K and your hospital electrolyte protocol. IV phosphate is for symptoms, severe lows or no gut — not for the convenience of one dose.
Real-life ward tips
⌄
- Patient fails the SBT for "no clear reason"? Check phos and Mg. Weak diaphragm from low phos is easy to fix.
- Draw the urine before you replace. One spot urine P + Cr gives you the FEPO₄ and saves a big workup.
- Low phos with low Mg — fix the Mg too (Mg loss makes the kidney waste phosphate and K).
- Alcohol withdrawal admission: phos is often normal on day 1 and crashes on day 2–3 when the patient eats and gets dextrose. Recheck.
- Do not run IV phosphate and calcium in the same line — they precipitate.
- IV phos can drop the calcium (Ca binds P). In a patient with low Ca, give oral phos or correct Ca first.
- mg vs mmol errors: "phosphorus 250" on a tablet = 8 mmol, not 250 mmol.
- Mild low phos (2.0–2.4) and asymptomatic in a patient who is eating? Often you can just let them eat (dairy, meat) and recheck — no pill needed.
- Recent IV iron infusion clinic visit? Think FGF23. Tell the iron clinic — switch product next time.
Pitfalls
⌄
- Starting full-calorie feeds in a starved patient without checking phos/K/Mg.
- Giving KPhos to a patient with K 5.2 or AKI.
- Full IV dose in CrCl <30 → hyperphosphatemia and low Ca.
- Routine phos replacement in DKA — no benefit, more hypocalcemia.
- Giving oral phos with the calcium tablet or sevelamer.
- Forgetting thiamine before dextrose/feeds in alcohol use disorder.
Board corner
⌄
| Stem | Answer |
|---|---|
| Alcohol use disorder, day 3, eating, new weakness and hemolysis, phos 0.6 | Refeeding → IV phosphate |
| Anorexia nervosa, tube feeds started, 48 h later HF and phos 0.9 | Refeeding syndrome |
| Ventilated, failing SBT, phos 1.1 | Replete phos (diaphragm weakness) |
| DKA on insulin, phos 1.8, stable | No routine phos replacement |
| Low phos 3 weeks after ferric carboxymaltose, FEPO₄ 25% | FGF23-mediated renal wasting |
| Low phos + glucosuria (normal glucose) + aminoaciduria on tenofovir | Fanconi syndrome |
| Low phos, high PTH, low Ca, low 25-OH D | Vitamin D deficiency (secondary hyperPTH) |
| Low phos, high Ca, high PTH | Primary hyperparathyroidism |
| Hyperventilation/panic, phos 1.6 | Respiratory alkalosis → shift |
| FEPO₄ 2% | Kidney is saving it → GI loss, intake or shift |
| Child with rickets, low phos, high FGF23 | X-linked hypophosphatemia → burosumab |
References
⌄
- Felsenfeld AJ, Levine BS. Approach to treatment of hypophosphatemia. Am J Kidney Dis. 2012;60:655.
- Gaasbeek A, Meinders AE. Hypophosphatemia: an update on its etiology and treatment. Am J Med. 2005;118:1094.
- da Silva JSV, et al. ASPEN consensus recommendations for refeeding syndrome. Nutr Clin Pract. 2020;35:178.
- Brown KA, et al. A new graduated dosing regimen for phosphorus replacement in patients receiving nutrition support. JPEN. 2006;30:209.
- Umpierrez GE, et al. Hyperglycemic crises in adult patients with diabetes: a consensus report. Diabetes Care. 2024;47:1257.
- Wolf M, et al. Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia (PHOSPHARE-IDA). JAMA. 2020;323:432.
- Imel EA, et al. Burosumab versus conventional therapy in children with X-linked hypophosphataemia. Lancet. 2019;393:2416.